Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Microsoft, Chipotle, Intuitive Surgical

Wed, 22nd Jul 2015 14:25

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks fell in early trading on Wednesday afterdisappointing results from technology giants including Apple,the world's largest publicly traded company. The Dow Jonesindustrial average was down 0.12 percent at 17,897.7, theS&P 500 was down 0.10 percent at 2,116.99 and the NasdaqComposite was down 0.58 percent at 5,177.793.

** APPLE INC, $124.41, -4.85 pct

The company's fourth-quarter revenue forecast fell short ofestimates and it missed some targets for iPhone sales. Theforecast overshadowed Apple's strong sales in China, which morethan doubled to $13.23 billion from a year earlier.

** CHIPOTLE MEXICAN GRILL INC, $724.64, +7.66 pct

The Burrito chain reported a better-than-expected quarterlyprofit as margins rose due to lower ingredient costs. Piper Jaffray, JP Morgan raised price targets.

** INTUITIVE SURGICAL INC, $560.36, +10.94 pct

The robotic surgical equipment maker reported abetter-than-expected quarterly profit and forecast surgicalprocedures to grow 11 to 13 percent this year, sending itsshares up 13 percent.

** BIOGEN, $397.09, -3.03 pct

A 6 mg dose of the drugmaker's experimental Alzheimer'sdisease drug significantly reduced beta amyloid plaque in thebrain but failed to significantly slow mental decline,potentially tempering great enthusiasm that greeted data on twoother doses of the treatment earlier this year.

** XOMA CORP, $1.0788, -75.45 pct

The drug developer says its experimental treatment for aninflammatory disease failed to meet main goal of late-stagestudy. The company says the compound, gevokizumab, was notbetter than a placebo in reducing risk of inflammation inpatients's blood vessels in the eye.

** ABBOTT LABORATORIES INC, $50.9, +2.29 pct

The company reported a slightly better-than-expectedquarterly profit, helped by higher sales of its brandedgenerics.

** LIPOCINE INC, $13.04, +10.60 pct

Analysts at Roth Capital start coverage of the drugmaker'sstock with "buy" rating. We believe Lipocine's LPCN 1021, whichis an oral T formulation, is on track to become the firstlandmark product in the category since the popular Androdermgel's launch in 2000", analysts say.

** MICROSOFT CORP, $46.1801, -2.33 pct

The company reported a $3.2 billion quarterly net loss, itsbiggest ever, as the company wrote down its Nokia phone businessand demand fell for its Windows operating system. The companytook a charge of $7.5 billion in the fourth quarter related tothe restructuring of its Nokia handset business, which it boughtlast year.

** YAHOO INC, $39.07, -1.66 pct

The company forecast lower-than-expected revenue for thecurrent quarter as it struggles to revive its core onlineadvertising business and spends more to attract users to itswebsites.

** REGULUS THERAPEUTICS INC, $9.57, -6.27 pct

Sources cite UBS reoffering 2.33 mln shares versus stock's$10.21 close; expected price and seller(s) not known.

** BOEING CO, $147.92, +2.01 pct

Boeing Co BA.N topped earnings estimates and doubled itsclosely watched quarterly cash flow, partly offsetting a bigcharge for its aerial tanker program.

** THORATEC CORP, $63.07, +9.53 pct

** ST JUDE MEDICAL INC, $77.26, +0.72 pct

Medical device maker St Jude Medical agreed to buy smallerrival Thoratec Corp for about $3.4 billion to expand itsportfolio of heart failure devices.

** AUTONATION, $62.56, -3.34 pct

The largest U.S. auto retailer, reported a 15 percent risein quarterly profit as an improving economy and low oil pricesboosted vehicle sales.

** BHP BILLITON, $38.29, -3.50 pct

** CLIFFS NATURAL RESOURCES INC, $2.56, -12.33 pct

London copper at two-week lows, Chinese steel &iron ore futures fall as demand weakens.

All four of BHP's "four pillars of growth" currently atmulti-year lows and forward price curves charted by Reuterssuggest that is unlikely to change soon. The world's biggestminer has 10 major commodities, including iron ore, copper,petroleum products and coal.

** THERMO FISHER SCIENTIFIC INC, $139.84, +2.47 pct

The world's largest maker of scientific instruments reporteda better-than-expected quarterly profit, helped by lower costsand strength in its life sciences unit.

** INTERPUBLIC GROUP OF COS INC, $20.4, +3.03 pct

The Advertising company's second-quarter revenue trumpedexpectations for the seventh straight quarter as higheradvertising spending by U.S. businesses made up for the strongdollar's impact on international revenue. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

More News
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.